0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Picture of the Month—Diagnosis FREE

[+] Author Affiliations

Section Editor: Samir S. Shah, MD
Section Editor: Albert C. Yan, MD

More Author Information
Arch Pediatr Adolesc Med. 2007;161(10):1002. doi:10.1001/archpedi.161.10.1001-b.
Text Size: A A A
Published online

DENOUEMENT AND DISCUSSION: PERIOCULAR HEMANGIOMA: AN EYE-OPENING EXPERIENCE

Clinical presentation and results of ophthalmologic examination, ultrasonography, and magnetic resonance imaging were consistent with the diagnosis of a deep infantile hemangioma involving the right orbit and upper and lower eyelids, causing proptosis, lateral displacement of the globe, and complete obstruction of the visual axis. Treatment with oral corticosteroids (prednisolone; initial dose, 2 mg/kg/d) had been started at 10 weeks of age and was then increased 2 weeks later (to 2 × 6 mg/kg/d) because of inadequate response. However, the hemangioma continued growing, and by 14 weeks of age, her electroretinogram showed signs of right postretinal dysfunction. In view of this sight-threatening progress, a multidisciplinary decision was made for surgical intervention.

At the age of 17 weeks, the major bulk of the hemangioma (4.5 × 3 × 2 cm) was excised in a joint procedure by a pediatric plastic surgeon (D.D.) and an ophthalmic surgeon (Y.A.) (Figure 3). There were no postoperative complications and the baby was able to open both eyes immediately after surgery. Histopathological examination, including positive erythrocyte-type glucose transporter protein (GLUT-1) staining of the endothelium, confirmed the diagnosis of infantile hemangioma.

Place holder to copy figure label and caption
Figure 3.

Excision of the major bulk of the tumor, measuring 4.5 × 3 × 2 cm.

Graphic Jump Location

To prevent regrowth of the residual hemangioma, prednisolone was continued on a tapering regimen and its use was finally discontinued by the age of 7 months. Patching of the unaffected left eye was performed for 30 minutes a day. A photograph 2 months postsurgery (Figure 4) shows the excellent functional and cosmetic result. The proptosis and lateral displacement of the globe had fully resolved and, importantly, both electroretinogram and visual evoked potentials proved to be normal for each eye on repeated testing. When last seen at the age of 9 months, the patient was well and there was no rebound growth of the residual hemangioma.

Place holder to copy figure label and caption
Figure 4.

Presentation at 10 weeks postsurgery.

Graphic Jump Location

Infantile hemangioma is the most common benign tumor of infancy, occurring in 4% to 10% of children.1 Hemangiomas are usually absent at birth or present only as precursor lesions and have a characteristic natural history of rapid growth within the first 3 to 6 months of life, followed by spontaneous involution over several years.2 Most hemangiomas are asymptomatic and can be managed by observation; however, a few may cause significant complications. Periocular hemangiomas can lead to severe and permanent visual disturbances by occluding the visual axis, compressing the globe, or expanding into the retrobulbar space. The diagnosis is usually established clinically, but imaging studies should be considered if there is a concern regarding other orbital soft tissue tumors (rhabdomyosarcoma, neuroblastoma, plexiform neurofibroma, or lymphatic malformation) and to assess the full extent of the tumor.3 During the growth phase of periocular hemangiomas, patients warrant close evaluation and follow-up by a multidisciplinary team comprising an ophthalmologist, dermatologist/pediatrician, and ideally a plastic surgeon. Systemic corticosteroids are the treatment of choice for hemangiomas that cause visual compromise. Other treatment options include intralesional or topical corticosteroids, interferon-α, and surgery, but their use may be limited by potential risks or lack of efficacy.3 The vascular nature of these lesions poses the challenge of potentially significant hemorrhage and surgical intervention is therefore often avoided. However, as we report herein in a child with a sight-threatening periocular hemangioma who failed to respond to oral corticosteroids, surgical debulking can be a valuable treatment option to save vision with an excellent cosmetic result.

Correspondence: Lisa Weibel, MD, Dermatology Department, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland (lisaweibel@yahoo.de).

Accepted for Publication: December 5, 2006.

Author Contributions:Study concept and design: Weibel, Hoey, Harper, Dunaway, and Abou-Rayyah. Acquisition of data: Weibel. Analysis and interpretation of data: Weibel, Syed, and Harper. Drafting of the manuscript: Weibel, Hoey, Syed, and Dunaway. Critical revision of the manuscript for important intellectual content: Harper and Abou-Rayyah. Administrative, technical, and material support: Weibel, Hoey, Dunaway, and Abou-Rayyah. Study supervision: Harper.

Financial Disclosure: None reported.

Funding/Support: Dr Weibel's fellowship at Great Ormond Street Hospital is financially supported by a nonrestricted grant from the Novartis Foundation and Spirig Pharma AG, Switzerland.

Frieden  IJHaggstrom  ANDrolet  BA  et al.  Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland USA. Pediatr Dermatol 2005;22 (5) 383- 406
PubMed Link to Article
Bruckner  ALFrieden  IJEsterly  NBHarper  J, Oranje A, Prose N, eds.ed Textbook of Pediatric Dermatology. Infantile hemangiomas and other vascular tumours.Vol 2. 2nd ed. Oxford, England Blackwell Publishing2006;1175- 1192
Ceisler  EJSantos  LBlei  F Periocular hemangiomas: what every physician should know. Pediatr Dermatol 2004;21 (1) 1- 9
PubMed Link to Article

Figures

Place holder to copy figure label and caption
Figure 3.

Excision of the major bulk of the tumor, measuring 4.5 × 3 × 2 cm.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 4.

Presentation at 10 weeks postsurgery.

Graphic Jump Location

Tables

References

Frieden  IJHaggstrom  ANDrolet  BA  et al.  Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland USA. Pediatr Dermatol 2005;22 (5) 383- 406
PubMed Link to Article
Bruckner  ALFrieden  IJEsterly  NBHarper  J, Oranje A, Prose N, eds.ed Textbook of Pediatric Dermatology. Infantile hemangiomas and other vascular tumours.Vol 2. 2nd ed. Oxford, England Blackwell Publishing2006;1175- 1192
Ceisler  EJSantos  LBlei  F Periocular hemangiomas: what every physician should know. Pediatr Dermatol 2004;21 (1) 1- 9
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Lobular Capillary Hemangioma of the Eyelid. Ophthal Plast Reconstr Surg Published online Oct 14, 2014.;
[Capillary hemangioma of the upper eyelid]. Pan Afr Med J 2014;17():175.